Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration (AMD)
This study is currently recruiting participants.
Verified September 2012 by Lions Eye Institute, Perth, Western Australia
Lions Eye Institute, Perth, Western Australia
Avalanche Biotechnologies, Inc.
Information provided by (Responsible Party):
Prof. P. Elizabeth Rakoczy, Lions Eye Institute, Perth, Western Australia
First received: December 14, 2011
Last updated: February 24, 2014
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||April 2017|
|Estimated Primary Completion Date:||April 2015 (Final data collection date for primary outcome measure)|